ResearchSafe

HCG (Human Chorionic Gonadotropin)

Category: Hormone Replacement. Status: FDA Approved.

A glycoprotein hormone that mimics luteinizing hormone (LH) to maintain testicular function during TRT. Preserves fertility, intratesticular testosterone production, and prevents testicular atrophy.

How it works

Binds LH/CG receptors on Leydig cells, stimulating intratesticular testosterone synthesis and maintaining spermatogenesis via local paracrine signaling independent of pituitary FSH/LH.

Key facts

  • Molecular weight: ~36,700 Da
  • Half-life: ~33 hours
  • Bioavailability: ~100% (subcutaneous/intramuscular)
  • Storage: Lyophilized: 2-8°C. Reconstituted: refrigerate, use within 30 days.

Dosing overview

  • Typical dose: 500-1000 IU
  • Frequency: 2-3x per week
  • Duration: Ongoing with TRT
  • Route: Subcutaneous injection

Reported benefits

  • Preserved testicular size
  • Maintained fertility on TRT
  • Intratesticular testosterone
  • Improved mood (neurosteroid support)
  • Pregnenolone/DHEA maintenance

Possible side effects

  • Estradiol elevation
  • Water retention
  • Gynecomastia risk
  • Desensitization at high doses
  • Injection site discomfort

Research

  • HCG co-administration during TRT (2019): Maintained intratesticular testosterone at 25% of baseline vs <5% in TRT-only group, preserving spermatogenesis.
  • HCG for male fertility preservation (2021): Combined HCG+FSH recovered sperm parameters in 67% of TRT-induced azoospermic men within 6 months.

Compare HCG

Community discussions about HCG

Research and educational reference only. Not medical advice.